ClinicalTrials.Veeva

Menu

Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial. (MucoSpuCo)

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Cystic Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT02309229
S54884 (Other Identifier)
ML8808

Details and patient eligibility

About

To use the sputum colour chart as a predictor for cystic fibrosis exaerbations

Full description

Patients will score their sputum purulence daily using three colour charts. They will also score for respiratory and other symptoms.

Primary analysis will focus on the predicting value of sputum purulence on exacerbations. Secondary analysis will evaluate symptoms on exacerbation prediction. A third subanalysis will focus on correlation of daily pollution fluctuations and sputum purulence or symptoms.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a diagnosis of cystic fibrosis
  • Pseudomonas aeruginosa colonization
  • at least 2 exacerbations in the previous year
  • at least 18 years of age

Exclusion criteria

  • colour blindness

Trial design

30 participants in 1 patient group

Cystic fibrosis patients
Description:
patients with cystic fibrosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems